![Carol-Ann Ohmstede](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Carol-Ann Ohmstede
Keine laufenden Positionen mehr
Karriereverlauf von Carol-Ann Ohmstede
Ehemalige bekannte Positionen von Carol-Ann Ohmstede
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Trimeris, Inc.
![]() Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Corporate Officer/Principal | 01.01.1998 | - |
Ausbildung von Carol-Ann Ohmstede
University of South Florida | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 3 |
Operativ
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Trimeris, Inc.
![]() Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Health Technology |
- Börse
- Insiders
- Carol-Ann Ohmstede
- Erfahrung